Prospective Study on Intensive Early Rheumatoid Arthritis Treatment
NCT00480272
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
251
Enrollment
OTHER
Sponsor class
Conditions
Rheumatoid Arthritis
Interventions
DRUG:
adalimumab, plus prednisone
DRUG:
adalimumab plus placebo
Sponsor
Fondazione IRCCS Policlinico San Matteo di Pavia